MSR1 and metabolic dysfunction-associated steatotic liver disease: Anti-macrophage scavenger receptor-1 (anti-MSR1) antibody (MSR1 inhibitor) may be an important therapeutic approach for the treatment of NAFLD requiring clinical investigations.